medigraphic.com
Revista Médica Sinergia

2019, Number 06

<< Back Next >>

Revista Médica Sinergia 2019; 4 (06)

Ovarian hyperstimulation syndrome: iatrogenic complication associated with assisted reproductive techniques

Pérez CN, Sainz MA, Camacho SAE

Language: Spanish
References: 20
Page: 40-52
PDF size: 590.87 Kb.


ABSTRACT

Ovarian hyperestimulation syndrome is one of the most serious iatrogenic complications of assisted reproductive techniques. This syndrome is mediated by the release of vasoactive factors from the cells of ovarian follicles developed through controlled ovarian stimulation, and it is mainly characterized by the increase in ovarian size along with a shift of fluid and proteins from the intravascular space into a third space. The diagnosis is mainly clinical, supported by pelvic ultrasound, and the management depends on its severity. It is possible to identify patients at risk, and preventive strategies should be applied prior, during and after the implementation of assisted reproductive techniques to lower the risk of developing this complication.


REFERENCES

  1. Humaidan P, Quartarolo J, Papanikolaou E. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertility and Sterility [en línea]. 2010 Jul [citado 26-marzo-2019]; 94(2): 389- 400. https://doi.org/10.1016/j.fertnstert.2010.03.028

  2. Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertility and Sterility [en línea]. 2016 Dec [citado 25-marzo-2019]; 106(7): 1634-1647.https://doi.org/10.1016/j.fertnstert.2016.08.048

  3. Olchowy A, Olchowy C, Łasecki M, Mazur R, Sierpowska M, Waligóra M et al. Ovarian Hyperstimulation Syndrome as a Growing Diagnostic Problem in Emergency Department Settings: A Case Report. The Journal of Emergency Medicine [en línea]. 2019 Feb [citado 26-marzo-2019]; 56(2): 217- 221. https://doi.org/10.1016/j.jemermed.2018.11.004

  4. Nelson SM. Prevention and management of ovarian hyperstimulation syndrome. Thromb Res [en línea]. 2017 Mar [22-marzo-2019]; 151: 61–64. https://doi.org/10.1016/S0049-3848(17)30070-1

  5. Elnory MA, Mahmoud Elmantwe AN. Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: A randomized clinical trial. Middle East Fertility Society Journal [en línea]. 2018 Dec [citado 28-marzo-2019]; 23(4): 357-362.https://doi.org/10.1016/j.mefs.2018.05.001

  6. Naredi N, Singh SK, Lele P, Nagraj N. Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach? Medical Journal Armed Forces India [en línea]. 2018 [citado 28-marzo- 2019];74(1):44-50. https://doi.org/10.1016/j.mjafi.2017.04.006

  7. Abou Arkoub R, Wei Xiao C, Claman P, Clark EG. Acute Kidney Injury Due to Ovarian Hyperestimulation Syndrome. Am J Kidney Dis [en línea]. 2019 Mar [citado 28-marzo-2019]; 73(3): 416- 420. https://doi.org/10.1053/j.ajkd.2018.10.010

  8. Tarlatzis BC, Bosdou JK, Kolibianakis EM. Ovarian Hyperstimulation Syndrome. Encyclopedia of Endocrine Diseases [en línea]. 2019 [citado 28-marzo-2019]; (2): 581-587.https://doi.org/10.1016/B978-0- 12-801238-3.95856-2

  9. Fatemi H, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropinreleasing hormone agonist trigger. Fertility and Sterility [en línea]. 2015 Apr [citado 30-marzo-2019]; 103(4): 870-873. https://doi.org/10.1016/j.fertnstert.2015.02.004

  10. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril [en línea]. 1992 Ago [citado 28-marzo-2019]; 58: 249- 261. https://doi.org/10.1016/S0015-0282(16)55188-7

  11. Shmorgun D, Claman P. No-268-The Diagnosis and Management of Ovarian Hyperstimulation Syndrome. J Obstet Gynaecol Can [en línea]. 2017 Nov [citado 30-marzo-2019]; 39(11): 479– 486.https://doi.org/10.1016/j.jogc.2017.09.003

  12. Balakumar V, Ramalingam M, Kay V. Ovarian hyperstimulation syndrome. Obstet Gynaecol Reprod Med [en línea]. 2017 Dec [citado 30-marzo-2019]; 27(12): 357-362.https://doi.org/10.1016/j.ogrm.2017.10.002

  13. Bellapu S, Guttman J. Use of Point-of-Care Ultrasound for the Diagnosis of Ovarian Hyperstimulation Syndrome. J Emerg Med [en línea]. 2017 Apr [citado 31-marzo-2019]; 52(4): 101– 104. https://doi.org/10.1016/j.jemermed.2016.11.026

  14. Namavar Jahromi B, Parsanezhad ME, Shomali Z, Bakhshai P, Alborzi M, Vaziri NM, et al. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran J Med Sci [en línea]. 2018 May [citado 22-marzo-2019]; 43(3): 248– 260. Disponible en: https://europepmc.org/articles/PMC5993897

  15. Sociedad Española de Ginecología y Obstetricia. Prevención y manejo del síndrome de hiperestimulación ovárica (2017). Prog Obstet Ginecol [en línea]. 2018 [citado 01-abril-2019]; 61 (4): 410-416. Disponible en: https://sego.es/documentos/progresos/v61-2018/n4/19_GAP%2023J.- %20Prevenci%C3%B3n%20y%20manejo%20del%20S%C3%ADndrome%20de%20hiperestimulaci%C3 %B3n%20ov%C3%A1rica%20(2017).pdf

  16. Lele P, Tangri M. A case of ovarian hyperstimulation syndrome with spontaneous hemoperitoneum. International Journal of Reproduction, Contraception, Obstetrics and Gynecology [en línea]. 2017 Dic [citado 23-abril-2019]; 6(2): 766-768. http://dx.doi.org/10.18203/2320-1770.ijrcog20170421

  17. Dincgez Cakmak B, Ozgen G, Dundar B, Ketenci Gencer F. Management of Bilateral Adnexal Torsion in a Case of Ovarian Hyperstimulation Syndrome. European Archives of Medical Research [en línea]. 2018 Set [citado 23-abril-2019]; 34(3): 196-199. Disponible en:https://www.journalagent.com/eamr/pdfs/EAMR_34_3_196_199.pdf

  18. Smith V, Osianlis T, Vollenhoven B. Prevention of Ovarian Hyperstimulation Syndrome: A Review. Obstetrics and Gynecology International [en línea]. 2015 May [citado 01-abril-2019]; 2015: article ID 514159. http://dx.doi.org/10.1155/2015/514159

  19. Fischer D, Reisenbüchler C, Rösner S, Haussmann J, Wimberger P, Goeckenjan M. Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS. Geburtshilfe Frauenheilkd [en línea]. 2016 Jun [citado 03-abril-2019]; 76(6): 718–726. https://doi.org/10.1055/s-0042-100206

  20. Nastri CO, Teixeira DM, Moroni RM, Leitão VMS, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol [en línea]. 2015 Mar [citado 03-abril-2019]; 45(4): 377-393. https://doi.org/10.1002/uog.14684




2020     |     www.medigraphic.com